Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Syncom Formulations (India) Limited (NSE: SYNCOMF), ISIN INE312C01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SYNCOMF last traded at ₹20.01 (-1.91%), with a 52-week range of ₹10.21 to ₹22.52 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 50.57%, FIIs 0.35%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 67/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.